Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Chevalier

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Rheumatology and Therapy|October 18, 2016
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisRobert Morlock, Pierre Chevalier, Laura Horne, et al.
Advances in Therapy|May 28, 2016
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective AnalysisFredrik Nyberg, Laura Horne, Robert Morlock, et al.
Journal of Medical Economics|March 24, 2023
Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and PortugalFabián P Alvarez, Pierre Chevalier, Matthias Borms, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 5, 2013
Antimicrobial-resistant Escherichia coli in public beach waters in QuebecPatricia Turgeon, Pascal Michel, Patrick Levallois, et al.
BMC Psychiatry|June 7, 2022
Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in France, Germany and BelgiumRui Cai, Flore Decuypere, Pierre Chevalier, et al.
The Science of the Total Environment|August 10, 2013
Prospective study of acute health effects in relation to exposure to cyanobacteriaBenoît Lévesque, Marie-Christine Gervais, Pierre Chevalier, et al.
Acta Clinica Belgica|September 26, 2019
Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry studyStef Meers, Benjamin Bailly, Isabelle Vande Broek, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 28, 2026
Quantifying Strain and Its Effect on Charge Transport in Ge/Si Core/Shell NanowiresAswathi K Sivan, Nicolas Forrer, Aakash Shandilya, et al.
Therapie|August 8, 2014
Translational research in immune and inflammatory diseases; what are the challenges, expected advances, and innovative therapies?Jean-Michel Joubert, Jacques-Eric Gottenberg, Gilles Paintaud, et al.
Nature Communications|August 15, 2025
Compromise-free scaling of qubit speed and coherenceMiguel J Carballido, Simon Svab, Rafael S Eggli, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Rheumatology and Therapy|October 18, 2016
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisRobert Morlock, Pierre Chevalier, Laura Horne, et al.
Advances in Therapy|May 28, 2016
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective AnalysisFredrik Nyberg, Laura Horne, Robert Morlock, et al.
Journal of Medical Economics|March 24, 2023
Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and PortugalFabián P Alvarez, Pierre Chevalier, Matthias Borms, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 5, 2013
Antimicrobial-resistant Escherichia coli in public beach waters in QuebecPatricia Turgeon, Pascal Michel, Patrick Levallois, et al.
BMC Psychiatry|June 7, 2022
Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in France, Germany and BelgiumRui Cai, Flore Decuypere, Pierre Chevalier, et al.
The Science of the Total Environment|August 10, 2013
Prospective study of acute health effects in relation to exposure to cyanobacteriaBenoît Lévesque, Marie-Christine Gervais, Pierre Chevalier, et al.
Acta Clinica Belgica|September 26, 2019
Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry studyStef Meers, Benjamin Bailly, Isabelle Vande Broek, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 28, 2026
Quantifying Strain and Its Effect on Charge Transport in Ge/Si Core/Shell NanowiresAswathi K Sivan, Nicolas Forrer, Aakash Shandilya, et al.
Therapie|August 8, 2014
Translational research in immune and inflammatory diseases; what are the challenges, expected advances, and innovative therapies?Jean-Michel Joubert, Jacques-Eric Gottenberg, Gilles Paintaud, et al.
Nature Communications|August 15, 2025
Compromise-free scaling of qubit speed and coherenceMiguel J Carballido, Simon Svab, Rafael S Eggli, et al.
Pageof 3